Reverse Genetics in Predicts ARF Cycling Is Essential for Drug Resistance and Virulence

1. NucciM

MarrKA

2005 Emerging fungal diseases. Clin Infect Dis 41 521 526

2. PappasPG

KauffmanCA

AndesD

BenjaminDKJr

CalandraTF

2009 Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 48 503 535

3. PfallerMA

DiekemaDJ

2007 Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20 133 163

4. WilsonLS

ReyesCM

StolpmanM

SpeckmanJ

AllenK

2002 The direct cost and incidence of systemic fungal infections. Value Health 5 26 34

5. ShaoPL

HuangLM

HsuehPR

2007 Recent advances and challenges in the treatment of invasive fungal infections. Int J Antimicrob Agents 30 487 495

6. RichardsonM

Lass-FlorlC

2008 Changing epidemiology of systemic fungal infections. Clin Microbiol Infect 14 Suppl 4 5 24

7. Pfaller MichaelA

Pappas PeterG

Wingard JohnR

2006 Invasive Fungal Pathogens: Current Epidemiological Trends. Clinical Infectious Diseases 43 S3 S14

8. LeroyO

GangneuxJP

MontraversP

MiraJP

GouinF

2009 Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006). Crit Care Med 37 1612 1618

9. PfallerMA

DiekemaDJ

2004 Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 42 4419 4431

10. CowenL

2008 The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype. Nat Rev Micro 6 187 198

11. ChapmanSW

SullivanDC

ClearyJD

2008 In search of the holy grail of antifungal therapy. Trans Am Clin Climatol Assoc 119 197 215; discussion 215–196

12. CowenLE

SteinbachWJ

2008 Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance. Eukaryot Cell 7 747 764

13. CannonRD

LampingE

HolmesAR

NiimiK

BaretPV

2009 Efflux-mediated antifungal drug resistance. Clin Microbiol Rev 22 291 321, table of contents

14. TraederC

KowollS

ArastehK

2008 Candida infection in HIV positive patients 1985–2007. Mycoses 51 Suppl 2 58 61

15. PachlJ

SvobodaP

JacobsF

VandewoudeK

van der HovenB

2006 A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis. Clin Infect Dis 42 1404 1413

16. CowenLE

SinghSD

KohlerJR

CollinsC

ZaasAK

2009 Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease. Proc Natl Acad Sci U S A 106 2818 2823

17. SinghSD

RobbinsN

ZaasAK

SchellWA

PerfectJR

2009 Hsp90 governs echinocandin resistance in the pathogenic yeast Candida albicans via calcineurin. PLoS Pathog 5 e1000532 doi:10.1371/journal.ppat.1000532

18. CruzMC

GoldsteinAL

BlankenshipJR

Del PoetaM

DavisD

2002 Calcineurin is essential for survival during membrane stress in Candida albicans. EMBO J 21 546 559

19. SanglardD

IscherF

MarchettiO

EntenzaJ

BilleJ

2003 Calcineurin A of Candida albicans: involvement in antifungal tolerance, cell morphogenesis and virulence. Mol Microbiol 48 959 976

20. CowenLE

LindquistS

2005 Hsp90 potentiates the rapid evolution of new traits: drug resistance in diverse fungi. Science 309 2185 2189

21. MarchettiO

EntenzaJM

SanglardD

BilleJ

GlauserMP

2000 Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans. Antimicrob Agents Chemother 44 2932 2938

22. SteinbachWJ

ReedyJL

CramerRAJr

PerfectJR

HeitmanJ

2007 Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections. Nat Rev Microbiol 5 418 430

23. LopezA

ParsonsAB

NislowC

GiaeverG

BooneC

2008 Chemical-genetic approaches for exploring the mode of action of natural products. Prog Drug Res 66 237, 239 271

24. HoonS

SmithAM

WallaceIM

SureshS

MirandaM

2008 An integrated platform of genomic assays reveals small-molecule bioactivities. Nat Chem Biol 4 498 506

25. HoCH

MagtanongL

BarkerSL

GreshamD

NishimuraS

2009 A molecular barcoded yeast ORF library enables mode-of-action analysis of bioactive compounds. Nat Biotechnol 27 369 377

26. ButcherRA

BhullarBS

PerlsteinEO

MarsischkyG

LaBaerJ

2006 Microarray-based method for monitoring yeast overexpression strains reveals small-molecule targets in TOR pathway. Nat Chem Biol 2 103 109

27. GiaeverG

FlahertyP

KummJ

ProctorM

NislowC

2004 Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. Proc Natl Acad Sci U S A 101 793 798

28. XuD

JiangB

KetelaT

LemieuxS

VeilletteK

2007 Genome-wide fitness test and mechanism-of-action studies of inhibitory compounds in Candida albicans. PLoS Pathog 3 e92 doi:10.1371/journal.ppat.0030092

29. JansenG

LeeAY

EppE

FredetteA

SurprenantJ

2009 Chemogenomic profiling predicts antifungal synergies. Mol Syst Biol 5 338

30. UccellettiD

FarinaF

MorlupiA

PalleschiC

1999 Mutants of Kluyveromyces lactis with altered protein glycosylation are affected in cell wall morphogenesis. Res Microbiol 150 5 12

31. DeanN

1995 Yeast glycosylation mutants are sensitive to aminoglycosides. Proc Natl Acad Sci U S A 92 1287 1291

32. DeanN

PosterJB

1996 Molecular and phenotypic analysis of the S. cerevisiae MNN10 gene identifies a family of related glycosyltransferases. Glycobiology 6 73 81

33. MorschhauserJ

2002 The genetic basis of fluconazole resistance development in Candida albicans. Biochim Biophys Acta 1587 240 248

34. KanafaniZA

PerfectJR

2008 Antimicrobial resistance: resistance to antifungal agents: mechanisms and clinical impact. Clin Infect Dis 46 120 128

35. MorschhauserJ

BarkerKS

LiuTT

BlaBWJ

HomayouniR

2007 The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans. PLoS Pathog 3 e164 doi:10.1371/journal.ppat.0030164

36. DunkelN

LiuTT

BarkerKS

HomayouniR

MorschhauserJ

2008 A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate. Eukaryot Cell 7 1180 1190

37. PoonPP

WangX

RotmanM

HuberI

CukiermanE

1996 Saccharomyces cerevisiae Gcs1 is an ADP-ribosylation factor GTPase-activating protein. Proc Natl Acad Sci U S A 93 10074 10077

38. MossJ

VaughanM

1998 Molecules in the ARF orbit. J Biol Chem 273 21431 21434

39. PoonPP

CasselD

SpangA

RotmanM

PickE

1999 Retrograde transport from the yeast Golgi is mediated by two ARF GAP proteins with overlapping function. EMBO J 18 555 564

40. PoonPP

NothwehrSF

SingerRA

JohnstonGC

2001 The Gcs1 and Age2 ArfGAP proteins provide overlapping essential function for transport from the yeast trans-Golgi network. J Cell Biol 155 1239 1250

41. MyersKR

CasanovaJE

2008 Regulation of actin cytoskeleton dynamics by Arf-family GTPases. Trends Cell Biol 18 184 192

42. GillinghamAK

MunroS

2007 The small G proteins of the Arf family and their regulators. Annu Rev Cell Dev Biol 23 579 611

43. SingletonVL

BohonosN

UllstrupAJ

1958 Decumbin, a new compound from a species of Penicillium. Nature 181 1072 1073

44. RenaultL

GuibertB

CherfilsJ

2003 Structural snapshots of the mechanism and inhibition of a guanine nucleotide exchange factor. Nature 426 525 530

45. CherfilsJ

MenetreyJ

MathieuM

Le BrasG

RobineauS

1998 Structure of the Sec7 domain of the Arf exchange factor ARNO. Nature 392 101 105

46. GoldbergJ

1998 Structural basis for activation of ARF GTPase: mechanisms of guanine nucleotide exchange and GTP-myristoyl switching. Cell 95 237 248

47. SataM

MossJ

VaughanM

1999 Structural basis for the inhibitory effect of brefeldin A on guanine nucleotide-exchange proteins for ADP-ribosylation factors. Proc Natl Acad Sci U S A 96 2752 2757

48. MossessovaE

CorpinaRA

GoldbergJ

2003 Crystal structure of ARF1*Sec7 complexed with Brefeldin A and its implications for the guanine nucleotide exchange mechanism. Mol Cell 12 1403 1411

49. ZnaidiS

De DekenX

WeberS

RigbyT

NantelA

2007 The zinc cluster transcription factor Tac1p regulates PDR16 expression in Candida albicans. Mol Microbiol 66 440 452

50. StevensDA

EspirituM

ParmarR

2004 Paradoxical effect of caspofungin: reduced activity against Candida albicans at high drug concentrations. Antimicrob Agents Chemother 48 3407 3411

51. FleischhackerM

RadeckeC

SchulzB

RuhnkeM

2008 Paradoxical growth effects of the echinocandins caspofungin and micafungin, but not of anidulafungin, on clinical isolates of Candida albicans and C. dubliniensis. Eur J Clin Microbiol Infect Dis 27 127 131

52. BrunoVM

KalachikovS

SubaranR

NobileCJ

KyratsousC

2006 Control of the C. albicans cell wall damage response by transcriptional regulator Cas5. PLoS Pathog 2 e21 doi:10.1371/journal.ppat.0020021

53. KarababaM

ValentinoE

PardiniG

CosteAT

BilleJ

2006 CRZ1, a target of the calcineurin pathway in Candida albicans. Molecular Microbiology 59 1429 1451

54. LepakA

NettJ

LincolnL

MarchilloK

AndesD

2006 Time course of microbiologic outcome and gene expression in Candida albicans during and following in vitro and in vivo exposure to fluconazole. Antimicrob Agents Chemother 50 1311 1319

55. SellamA

TebbjiF

NantelA

2009 Role of Ndt80p in sterol metabolism regulation and azole resistance in Candida albicans. Eukaryot Cell 8 1174 1183

56. LiuTT

LeeRE

BarkerKS

WeiL

HomayouniR

2005 Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob Agents Chemother 49 2226 2236

57. WhitewayM

BachewichC

2007 Morphogenesis in Candida albicans. Annu Rev Microbiol 61 529 553

58. MullickA

EliasM

PicardS

BourgetL

JovcevskiO

2004 Dysregulated inflammatory response to Candida albicans in a C5-deficient mouse strain. Infect Immun 72 5868 5876

59. GauwerkyK

BorelliC

KortingHC

2009 Targeting virulence: a new paradigm for antifungals. Drug Discov Today 14 214 222

60. SellamA

AskewC

EppE

LavoieH

WhitewayM

2009 Genome-wide mapping of the coactivator Ada2p yields insight into the functional roles of SAGA/ADA complex in Candida albicans. Mol Biol Cell 20 2389 2400

61. SanglardD

IscherF

ParkinsonT

FalconerD

BilleJ

2003 Candida albicans mutations in the ergosterol biosynthetic pathway and resistance to several antifungal agents. Antimicrob Agents Chemother 47 2404 2412

62. TimmersHT

ToraL

2005 SAGA unveiled. Trends Biochem Sci 30 7 10

63. ZnaidiS

WeberS

Al-AbdinOZ

BommeP

SaidaneS

2008 Genomewide location analysis of Candida albicans Upc2p, a regulator of sterol metabolism and azole drug resistance. Eukaryot Cell 7 836 847

64. LiuTT

ZnaidiS

BarkerKS

XuL

HomayouniR

2007 Genome-wide expression and location analyses of the Candida albicans Tac1p regulon. Eukaryot Cell 6 2122 2138

65. TuchBB

LiH

JohnsonAD

2008 Evolution of eukaryotic transcription circuits. Science 319 1797 1799

66. HoguesH

LavoieH

SellamA

MangosM

RoemerT

2008 Transcription factor substitution during the evolution of fungal ribosome regulation. Mol Cell 29 552 562

67. AskewC

SellamA

EppE

HoguesH

MullickA

2009 Transcriptional Regulation of Carbohydrate Metabolism in the Human Pathogen Candida albicans. PLoS Pathog 5 e1000612 doi:10.1371/journal.ppat.1000612

68. JiaN

Arthington-SkaggsB

LeeW

PiersonCA

LeesND

2002 Candida albicans sterol C-14 reductase, encoded by the ERG24 gene, as a potential antifungal target site. Antimicrob Agents Chemother 46 947 957

69. SanglardD

CosteA

FerrariS

2009 Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation. FEMS Yeast Res 9 1029 1050

70. CowenL

SteinbachW

2008 Stress, Drugs, and Evolution: the Role of Cellular Signaling in Fungal Drug Resistance. Eukaryotic Cell 7 747 764

71. d'EnfertC

2009 Hidden killers: persistence of opportunistic fungal pathogens in the human host. Curr Opin Microbiol 12 358 364

72. BruningA

IshikawaT

KneuselRE

MaternU

LottspeichF

1992 Brefeldin A binds to glutathione S-transferase and is secreted as glutathione and cysteine conjugates by Chinese hamster ovary cells. J Biol Chem 267 7726 7732

73. FoxBM

VromanJA

FanwickPE

CushmanM

2001 Preparation and evaluation of sulfide derivatives of the antibiotic brefeldin a as potential prodrug candidates with enhanced aqueous solubilities. J Med Chem 44 3915 3924

74. AnaduNO

DavissonVJ

CushmanM

2006 Synthesis and anticancer activity of brefeldin A ester derivatives. J Med Chem 49 3897 3905

75. ShaoRG

ShimizuT

PommierY

1996 Brefeldin A is a potent inducer of apoptosis in human cancer cells independently of p53. Exp Cell Res 227 190 196

76. ZhuJ-W

HoriH

NojiriH

TsukudaT

TairaZ

1997 Synthesis and activity of brefeldin a analogs as inducers of cancer cell differentiation and apoptosis. Bioorganic & Medicinal Chemistry Letters 7 139 144

77. ZhuJW

NagasawaH

NaguraF

MohamadSB

UtoY

2000 Elucidation of strict structural requirements of brefeldin A as an inducer of differentiation and apoptosis. Bioorg Med Chem 8 455 463

78. NojiriH

ManyaH

IsonoH

YamanaH

NojimaS

1999 Induction of terminal differentiation and apoptosis in human colonic carcinoma cells by brefeldin A, a drug affecting ganglioside biosynthesis. FEBS Lett 453 140 144

79. GuoH

TittleTV

AllenH

MaziarzRT

1998 Brefeldin A-mediated apoptosis requires the activation of caspases and is inhibited by Bcl-2. Exp Cell Res 245 57 68

80. HackiJ

EggerL

MonneyL

ConusS

RosseT

2000 Apoptotic crosstalk between the endoplasmic reticulum and mitochondria controlled by Bcl-2. Oncogene 19 2286 2295

81. SahaiE

MarshallCJ

2002 RHO-GTPases and cancer. Nat Rev Cancer 2 133 142

82. DownwardJ

2003 Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3 11 22

83. SabeH

OnoderaY

MazakiY

HashimotoS

2006 ArfGAP family proteins in cell adhesion, migration and tumor invasion. Curr Opin Cell Biol 18 558 564

84. CherfilsJ

ChardinP

1999 GEFs: structural basis for their activation of small GTP-binding proteins. Trends Biochem Sci 24 306 311

85. AmorJC

HortonJR

ZhuX

WangY

SullardsC

2001 Structures of yeast ARF2 and ARL1: distinct roles for the N terminus in the structure and function of ARF family GTPases. J Biol Chem 276 42477 42484

86. MarchettiO

MoreillonP

GlauserMP

BilleJ

SanglardD

2000 Potent synergism of the combination of fluconazole and cyclosporine in Candida albicans. Antimicrob Agents Chemother 44 2373 2381

87. BaderT

BodendorferB

SchroppelK

MorschhauserJ

2003 Calcineurin is essential for virulence in Candida albicans. Infect Immun 71 5344 5354

88. BlankenshipJR

HeitmanJ

2005 Calcineurin is required for Candida albicans to survive calcium stress in serum. Infect Immun 73 5767 5774

89. (SGD project. The Saccharomyces Genome Database, www.yeastgenome.org (as of October 2009))

90. DavisDA

BrunoVM

LozaL

FillerSG

MitchellAP

2002 Candida albicans Mds3p, a conserved regulator of pH responses and virulence identified through insertional mutagenesis. Genetics 162 1573 1581

91. ArnaudMB

CostanzoMC

SkrzypekMS

ShahP

BinkleyG

2007 Sequence resources at the Candida Genome Database. Nucleic Acids Res 35 D452 456

92. GolaS

MartinR

WaltherA

DünklerA

WendlandJ

2003 New modules for PCR-based gene targeting in Candida albicans: rapid and efficient gene targeting using 100 bp of flanking homology region. Yeast 20 1339 1347

93. ChenDC

YangBC

KuoTT

1992 One-step transformation of yeast in stationary phase. Curr Genet 21 83 84

94. WaltherA

WendlandJ

2008 PCR-based gene targeting in Candida albicans. Nat Protoc 3 1414 1421

95. BouchonvilleK

ForcheA

TangKE

SelmeckiA

BermanJ

2009 Aneuploid chromosomes are highly unstable during DNA transformation of Candida albicans. Eukaryot Cell 8 1554 1566

96. ArbourM

EppE

HoguesH

SellamA

LacroixC

2009 Widespread occurrence of chromosomal aneuploidy following the routine production of Candida albicans mutants. FEMS Yeast Res

97. ReussO

VikA

KolterR

MorschhäuserJ

2004 The SAT1 flipper, an optimized tool for gene disruption in Candida albicans. Gene 341 119 127

98. NobleSM

JohnsonAD

2005 Strains and Strategies for Large-Scale Gene Deletion Studies of the Diploid Human Fungal Pathogen Candida albicans. Eukaryotic Cell

99. NCCLS Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard-Second Edition. NCCLS document M27-A2 [ISBN 1-56238-469-4]. NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2002

100. LoeweS

1953 The problem of synergism and antagonism of combined drugs. Arzneimittelforschung 3 285 290

101. BarchiesiF

Di FrancescoLF

CompagnucciP

ArzeniD

GiacomettiA

1998 In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans. J Antimicrob Chemother 41 59 65

102. NCCLS Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi; Approved Standard. NCCLS document M38-A [ISBN 1-56238-470-8]. NCCLS, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2002

103. KohrerK

DomdeyH

1991 Preparation of high molecular weight RNA. Methods Enzymol 194 398 405

104. NantelA

RigbyT

HoguesH

WhitewayM

2006 Microarrays for studying pathogenicity in Candida albicans;

KavanaughKH

New Jersey Wiley Press